Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic stage IV head-and-neck squamous cell carcinomas

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages

  Prestwich, Robin J ^a   Öksüz, Didem Olpan ^a   Dyker, Karen ^a   Coyle, Catherine ^a   Şen, Mehmet ^a  

^a ST JAMES S INSTITUTE OF ONCOLOGY   (United Kingdom)

Author keywords

Cisplatin; Docetaxel; Head and neck cancer; Induction chemotherapy

Indexed keywords

5-FLUOROURACIL; AFTER-TREATMENT; CAUSE-SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; CIS-PLATIN; CISPLATIN 100; COMPLETE RESPONSE; CONCURRENT CHEMORADIOTHERAPY; CONCURRENT CISPLATIN; DISEASE PROGRESSION; DOCETAXEL; ENTERAL FEEDING; GASTROSTOMY; HEAD-AND-NECK CANCER; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; INDUCTION CHEMOTHERAPY; MEDIAN WEIGHT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADICAL RADIOTHERAPY; SQUAMOUS CELL CARCINOMA; TUMOR RESPONSE;

CHEMOTHERAPY; DISEASES; DRUG PRODUCTS; RADIOTHERAPY;

PLATINUM COMPOUNDS;

CARBOPLATIN; CIPROFLOXACIN; CISPLATIN; DEXAMETHASONE; DOCETAXEL; FLUOROURACIL; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CAUSE SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; DIARRHEA; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEMALE; GASTROSTOMY; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; HYDRATION; HYPERTRANSAMINASEMIA; INFECTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; ENTERAL NUTRITION; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; RADIATION-SENSITIZING AGENTS; TAXOIDS; WEIGHT LOSS;

EID: 80955179537     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.03.043     Document Type: Article

References (19)

1. T.Y. Seiwert, and E.E. Cohen State-of-the-art management of locally advanced head and neck cancer Br J Cancer 92 2005 1341 1348 (Pubitemid 40704997)
2. J.P. Pignon, A. le Maitre, and E. Maillard Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
3. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
4. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098 (Pubitemid 37464533)
5. J.B. Vermorken, E. Remenar, and C. Van Herpen Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704 (Pubitemid 350005151)
6. M.R. Posner, D.M. Hershock, and C.R. Blajman Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715 (Pubitemid 350005152)
7. Y. Pointreau, P. Garaud, and S. Chapet Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation J Natl Cancer Inst 101 2009 498 506
8. National Cancer Institute. Common terminology criteria for adverse events v3.0. Available at: http://ctep.cancer.gov/forms/CTCAEv3.pdf. Last accessed June 20,2010.
9. J.K. Salama, R.I. Haddad, and M.S. Kies Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 75 2009 725 733
10. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
11. P. Huguenin, K.T. Beer, and A. Allal Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy J Clin Oncol 22 2004 4665 4673
12. M. Machtay, J. Moughan, and A. Trotti Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis J Clin Oncol 26 2008 3582 3589
13. A. Paccagnella, M.G. Ghi, and L. Loreggian Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: A phase II randomized study Ann Oncol 21 2010 1515 1522
14. A.G. Morganti, S. Mignogna, and F. Deodato Feasibility study of moderately accelerated intensity-modulated radiotherapy plus concurrent weekly cisplatin after induction chemotherapy in locally advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 79 2011 1073 1080
15. R. Hitt, and A. Lopez-Pousa Chemotherapy (ICT) with cisplatin/5- fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC) (Abstr.) J Clin Oncol 23 Suppl. 1 2005 5515a
16. J.F. Fowler, and M.J. Lindstrom Loss of local control with prolongation in radiotherapy Int J Radiat Oncol Biol Phys 23 1992 457 467
17. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086 (Pubitemid 30019568)
18. J. Corry, W. Poon, and N. McPhee Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation Head Neck 31 2009 867 876
19. K.K. Ang, J. Harris, and R. Wheeler Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35